Key points are not available for this paper at this time.
"Just Accepted" papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. Purpose To evaluate the impact of an artificial intelligence (AI) assistant for lung cancer screening (LCS) on multinational clinical workflows. Materials and Methods An AI assistant for LCS was evaluated on two retrospective randomized multireader multicase studies, where 627 (141 cancer positive) low-dose chest CT cases were each read twice (with and without AI assistance) by experienced thoracic radiologists (6 US-based or 6 Japan-based), resulting in a total of 7,524 interpretations. Positive cases were defined as those within two years before a pathology-confirmed lung cancer diagnosis. Negative cases were defined as those without any subsequent cancer diagnosis for at least two years and were enriched for a spectrum of diverse nodules. The studies measured the readers' level of suspicion (LoS, on a 0–100 scale), country-specific screening system scoring categories, and management recommendations. Evaluation metrics included the area under the receiver operating characteristic curve (AUC) for LoS and sensitivity and specificity of recall recommendations. Results With AI assistance, the radiologists' AUC increased by 0.023 (0.70 to 0.72, P = .02) for the US study and by 0.023 (0.93 to 0.96, P = .18) for the Japan study. Scoring system specificity for actionable findings increased 5.5% (57%–63%, P .99) studies. Corresponding standalone AI AUC system performance was 0.75 95% CI 0.70–0.81 and 0.88 95%CI 0.78–0.97 for the US and Japan-based datasets, respectively. Conclusion The concurrent AI interface improved LCS specificity in both US and Japan-based reader studies, meriting further study in additional international screening environments. ©RSNA, 2024
Kiraly et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: